FHIR Release 3 (STU) R4 Ballot #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.0.2: STU 3). (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0318

Pharmacy Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Patient , Practitioner

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile MedicationDispense .

Generated Narrative with Details

id : meddisp0318

identifier : 12345689 (OFFICIAL)

status : in-progress

medication : Levothyroxine Sodium Tablets, USP (75mcg) (Details : {http://hl7.org/fhir/sid/ndc code '0378-1805-01' = '0378-1805-01', given as 'Levothyroxine Sodium Tablets, USP (75mcg)'})

subject : Donald Duck

Performers

OnBehalfOf Organization/2.16.840.1.113883.19.5
- Actor
* Practitioner/f006

authorizingPrescription : MedicationRequest/medrx0314

type : Refill - Part Fill (Details : {http://hl7.org/fhir/v3/ActCode {http://terminology.hl7.org/CodeSystem/v3-ActCode code 'RFP' = 'Refill - Part Fill', given as 'Refill - Part Fill'})

quantity : 100 TAB (Details: UCUM http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'TAB') 'Tablet')

daysSupply : 30 Day (Details: UCUM code d = 'd')

whenPrepared : 16/03/2015 5:13:00 PM

dosageInstruction :

Substitutions

- WasSubstituted Type Reason ResponsibleParty
* true formulary (Details : {http://hl7.org/fhir/v3/substanceAdminSubstitution {http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution code 'F' = 'formulary', given as 'formulary'}) Formulary Policy (Details : {http://hl7.org/fhir/v3/ActReason {http://terminology.hl7.org/CodeSystem/v3-ActReason code 'FP' = 'formulary policy', given as 'Formulary Policy'}) Practitioner/f006

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.